Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2008 December;56(6) > Minerva Cardioangiologica 2008 December;56(6):605-21

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions

 

REVIEWS   

Minerva Cardioangiologica 2008 December;56(6):605-21

Copyright © 2008 EDIZIONI MINERVA MEDICA

language: English

Treatment strategies in atrial fibrillation

Wong K. C. K., Betts T. R.

Cardiac Rhythm Management Cardiology Department John Radcliffe Hospital, Headington, Oxford, UK


PDF


Atrial fibrillation (AF) is the most common cardiac arrhythmia in clinical practice affecting up to 1% of the general population. There is a higher prevalence and incidence with increasing age and burden of chronic heart disease . Treatment for AF represents a significant healthcare cost, estimated to be about € 13.5 billion annually in the European Union. Manage-ment of AF remains challenging especially with new pharmacological and non-pharmacological approaches becoming readily available. This review article discusses the multitude of therapeutic options and how they may be applied to best effect.

top of page